Skip to main content

Full text of "USPTO Patents Application 09848616"

See other formats


Please type a sign (+) inside this box 



ffl 



PTO/SB/05 (03-01) 
Approved for use through 10/3 1/2002. OMB 0651-0032 
t t a *u Tt i t> J . Patent and Trademark Office: U.S. DEPARTMENT OF COMMERCE 

Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number- 



UTILITY 
PATENT APPLICATION 
TRANSMITTAL 

(Only for new nonprovisional applications under 3 7 CFR § 1 53(b) ) 



Attorney Docket No 



First Inventor 



Title 



1 700. 0180002/JAG/GER 



Peter Sebbel 



Molecular Antigen Array 



Express Mail Label No. 



APPLICATION ELEMENTS 

2 MPEP chapter 600 concerning utility patent application contents. 



ADDRESS TO: 



Assistant Commissioner for Patents 
Box Patent Application 
Washington, DC 20231 



1- □ 

2. H 

3. 13 



Fee Transmittal Form {e.g., PTO/SB/17) 

(Submit an original, and a duplicate for fee processing) 

Applicant claims small entity status. 
See 37 CFR 1.27. 

Specification [Total Pages | g J ] 

(preferred arrangement set forth below) 

- Descriptive title of the Invention 

- Cross Reference to Related Applications 

- Statement Regarding Fed sponsored R&D 

- Reference to sequence listing, a table, 
or a computer program listing appendix 

- Background of the Invention 

- Brief Summary of the Invention 

- Brief Description of the Drawings (if filed) 

- Detailed Description 

- Claim(s) 

- Abstract of the Disclosure 



7. □ CD-ROM or CD-R in duplicate, large table or Computer Program 

(Appendix) 

8. Nucleotide and/or Amino Acid Sequence Submission 



(if applicable, all necessary) 

a. ^3 Computer Readable Form (CRF) 

b. Specification Sequence Listing on: 

i. □ CD-ROM or CD-R (2 copies); or 

ii. paper 

c. £3 Statements verifying identity of above copies 



O 

— I 

CM i 

VOCF\ • 
COQ ' 

U i 



4. El 



Drawing(s) (35 U.S.C. 113) [Total Sheets 27 ] 

5. Oath or Declaration [Total Pages J 

a. □ Newly executed (original or copy) 

b. □ Copy from a prior application (37 CFR 1.63(d)) 
(for continuation/divisional with Box 18 completed) 

i. □ DELETION OF INVENTORY 

Signed statement attached deleting inventor(s) 
named in the prior application, see 37 CFR §§ 
1.63(d)(2) and 1.33(b). 

6. |3 Application Data Sheet. See 37 CFR 1.76. 



ACCOMPANYING APPLICATION PARTS 



9. 


□ 


10. 


□ 


11. 


□ 


12. 


□ 


13. 




14. 




15. 


□ 


16. 


□ 


17. 





Assignment Papers (cover sheet & document(s)) 

37 CFR 3.73(b) Statement □ Power of Attorney 
(when there is an assignee) 

English Translation Document (if applicable) 

Information Disclosure □ Copies of IDS 

Statement (IDS)/PTO-1449 Citations 

Preliminary Amendment 

Return Receipt Postcard (MPEP 503) 
(Should be specifically itemized) 

Certified Copy of Priority Document(s) 
(if foreign priority is claimed) 

Nonpubhcation Request under 35 U.S.C. 122 (b)(2)(B)(i). Applicant must attach 
form PTO/SB/35 or its equivalent. 

Other: Authorization under 37 C.F.R. § 1.136(aV3) 

Priority Claim Under 35 U.S.C. g 1 19(e) and 37 C.F.R . 
§ 1.78(a)(4) 

Rl Other: The name of the assignee is: Cvtos Biotechnology AG 



18. If a CONTINUING APPLICATION, check appropriate box, and supply the requisite information below and in a preliminary amendment, 
or in an Application Data Sheet under 3 7 CFR 1. 76. 

d Continuation □ Divisional □ Continuation- in-Part (C IP) of prior application No: / 

Pri^ application information: Examiner Group/ Art Unit: 



For CONTINUATION OR DIVISIONAL APPS only: The entire disclosure of the prior application, from which an oath or declaration is supplied under Box 5b, is 
considered a part of the disclosure of the accompanying continuation or divisional application and is hereby incorporated by reference. The incorporatio n can on ly 
relied upon when a portion has been inadvertently omitted from the submitted application parts. 



19. CORRESPONDENCE ADDRESS 



E>3 Customer Number or Bar Code Label 
Customer No. 26111 




bar code label here) 



I I Correspondence address below 



NAME 



Sterne, Kessler, Goldstein & Fox p.i 

kai tNi mAUkMAKK UJ-hlUb 



Attorneys at Law 



ADDRESS 



CITY 



STATE 



ZIP CODE 



COUNTRY 



TELEPHONE 



FAX 



NAME (Print/Type) 


Grant E. Ree^ / 




Registration No. (Attorney/Agent) 


41,264 f f | 


SIGNATURE 


X^-OSOL^ y| 


Date] SfHlOi 1 



Burden Hour Statement: this form is estimated tAtake 0.2 hours tcj complete. Time will vary depending upon the needs of the individual case. Any comments on the amount 
of time you are required to complete this fSqnjJrfuld be sent to uft Chief Information Officer, U.S. Patent and Trademark Office, Washington DC 20231 DO NOT SEND 
FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Assistant Commissioner for Patents, Box Patent Application, Washington DC 2023 1 



SKGF Rev 3/29/01 mac 



0 1 8-2 .NON-PROV.CVR. WPD 



JC860 U.S. PTO 




Sterne, Kessler, Goldstein & Fox p.l.l.c. 



ATTORNEYS AT LAW 
IIOO NEW YORK AVENUE, NW • WASHINGTON, DC 20005-3934 

Phone (2021 371-2600 • Facsimile (202) 371-2540 • wwwskgfcom 



Robert Greene Sterne John M Covert Lawrence B Bugaisky Vincent L Capuano Elizabeth J Haanes** 

Edward J. Kessler Linda E Alcorn Crystal D Sayles John A Harroun* Mark P Terry** 

Jorge A, Goldstein Robert C Millonig Edward W Yee Albert J Fasulou* Joseph M Conrad, III* 

Samuel L. Fox*** Michael V Messinger Albert L Ferro* Eldora Ellison Floyd* Douglas M Wilson** 

David K.S. Cornwell Judith U Kim Donald R Banowit w Russell Swindell Reginald D Lucas** 

Robert W. Esmond Timothy J Shea, Jr Peter A Jackman Thomas C Fiala Ann E Su m m erfi eld** 

Tracy-Gene G Durkin Donald R McPhail Molly A McCall Brian J Del Buono* Cynthia M Bouchez** 

MlCHELE A. ClMBALA PATRICK E GARRETT TERESA U MEDLER VlRGIL L BEASTON* HELENE C CARLSON** 

Michael B, Ray Jeffrey T Helvey* Jeffrey S Weaver Ryan J Stamper* Bruce E Chalker** 

Robert E. Sokohl Heidi L Kraus Kristin K Vidovich Karen R Markowicz** Dustin T Johnson** 

Eric K. Steffe Jeffrey R Kurin Kendrick P Patterson Suzanne E Ziska** Matthew J Dowd** 

Michael 0 Lee Raymond Millien Donald J Featherstone Andrea J Kamage** 

Steven R. Ludwig Patrick D O'Brien Grant E Reed Nancy J Leith** 



May 4, 2001 



♦Limited To Matters 

and Proceedings Before 
Federal Courts & Agencies 
'^Registered Patent Agent 
"'Senior Counsel 

Writer 's Direct Number: 

(202) 789-5507 



Commissioner for Patents Box Patent Application 

Washington, D.C. 20231 ° 



Re: U.S. Non-Provisional Patent Application under 37 C.F.R. § 1.53(b) 
Appl. No. To Be Assigned; Filed: May 4, 2001 
For: Molecular Antigen Array 
Inventors: Sebbel et al 




Our Ref: 1700.01 80002/JAG/GER 



Sir: 



The following documents are forwarded herewith for appropriate action by the U.S. 
Patent and Trademark Office: 



1 . USPTO Utility Patent Application Transmittal Form (PTO/SB/05); 



2. U.S. Utility Patent Application entitled: 
Molecular Antigen Array 

and naming as inventors: 



Peter Sebbel, 
Nicolas Dunant, 
Martin Bachmann, 
Alain Tissot, and 
Franziska Lechner; 



Stekne, Kesslee, Goldstein 6c Fox p.l.l.c. 



Commissioner for Patents 
May 4, 2001 
Page 2 



the application consisting of: 

a. A specification containing: 

i. 142 pages of description prior to the claims; 

ii. _18_ pages of claims (125 claims); 

iii. a one (1) page abstract; 

b. 2L sheets of drawings: (Figures 1, 2, 3, 4, 5 , 6, 7, 8, 9, 10, 1 1, 12, 
13, 14A, 14B, 15A, 15B, 16A, 16B, 17, 18A, 18B, 18C, 18D, 19A, 
19B,and 20); 

c. 100 pages of a paper copy of the sequence listing; 

d. A computer readable copy of the sequence listing. In accordance 
with 37 C.F.R. § 1.821(f), the paper copy of the sequence listing 
and the computer readable copy of the sequence listing submitted 
herewith in the above application are the same; 

e. an Application Data Sheet (37 C.F.R. § 1 .76); 

3 . Preliminary Amendment; 

4. Priority Claim Under 35 U.S.C. § 1 19(e) and 37 C.F.R. § 1 .78(a)(4); 

5. Authorization to Treat a Reply As Incorporating An Extension of Time 
Under 37 C.F.R. § 1.136(a)(3) (in duplicate); and 

6. Two (2) return postcards. 

The name of the assignee is Cytos Biotechnology AG. 
Send correspondence to Customer Number 261 1 1 . 

It is respectfully requested that, of the two attached postcards, one be stamped with the 
filing date of these documents and returned to our courier, and the other, prepaid postcard, be 
stamped with the filing date and unofficial application number and returned as soon as possible. 



Sterne, Kesslee, Goldstein 6c Fox p.h.l.c. 



Commissioner for Patents 
May 4, 2001 
Page 3 

This patent application is being submitted under 37 C.F.R. § 1.53(b) without Declaration 
and without filing fee. 



Respectfully submitted, 

Sterne, Kessler, Goldstein & Fox p.l.l.c. 



Grant/E. Reed 
Attorney for Applicants 
Registration No. 41,264 




Enclosures 



01 8-2.NON-PROV.TRANS.WPD